Ciji Smith
Family · Gilbert, AZNPI 1609582097
Payments from drug & device makers
Across 189 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$898
- AstraZeneca$852
- Novo Nordisk$447
- Lilly USA, LLC$134
- Amgen$113
- Astellas Pharma US Inc$97
- plus $751 from 21 others
What the payments were for
- Food & beverage$3,293100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $898 |
| AstraZeneca | 37 | $852 |
| Novo Nordisk | 28 | $447 |
| Lilly USA, LLC | 7 | $134 |
| Amgen | 7 | $113 |
| Astellas Pharma US Inc | 4 | $97 |
| Boehringer Ingelheim | 4 | $75 |
| Dexcom, Inc. | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Shield Therapeutics Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Pfizer | 2 | $40 |
| Boston Scientific | 2 | $38 |
| Exact Sciences | 2 | $38 |
| Bayer | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Corcept Therapeutics | 1 | $24 |
| Gilead | 1 | $24 |
| Axonics, Inc. | 1 | $23 |
| Saluda Medical Americas, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Merck | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,293 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $36,335 |
| MounjaroTirzepatide | 21 | $30,327 |
| Liothyronine Sodium | 23 | $611 |
| Levothyroxine Sodium | 55 | $471 |
| ProgesteroneProgesterone, Micronized | 15 | $336 |
| Atorvastatin Calcium | 32 | $294 |
| Omeprazole | 23 | $265 |
| Rosuvastatin Calcium | 25 | $257 |
| Pantoprazole Sodium | 19 | $254 |
| Famotidine | 11 | $248 |
| Lisinopril | 40 | $245 |
| Gabapentin | 14 | $222 |
| Losartan Potassium | 27 | $195 |
| Ezetimibe | 12 | $182 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $447 | $36,33525 claims |
| Lilly USA, LLCMounjaro | $134 | $30,32721 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $47155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.
Other family in Gilbert
- Celeste FineGilbert$82K
- Rechelle TrejoGilbert$34K
- Jonathan HenriquezGilbert$26K
- Arin LamoureauxGilbert$17K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.